Home > Drug Search >
  • Targets: Enhancer of zeste homolog 2 (EZH2)
  •   > 
Drug Filter
Status:
Phase Ⅲ (2) Phase Ⅱ (2) Phase Ⅰ (8)
Clinical Stage:
Pending (3) Active (6) Discontinued (3)
Company:
Eisai (1) GlaxoSmithKline (2) Merck Sharp & Dohme (1) Nippon Shinyaku Pharma (1) Onconova Therapeutics (1) Takeda (1) Nerviano Medical Sciences (1) Epizyme (1) Constellation (1) Calithera Biosciences (1) Boehringer Ingelheim (2)
Indication:
Acute myeloid Leukemia (AML) (2) Follicular lymphoma (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin B-cell lymphomas (1) Non-Hodgkin’s lymphoma (NHL) (2) Pancreatic cancer (1) Solid tumours (6) B-cell lymphoma (1) Hematological cancer (1) Chronic myelomonocytic leukemia(CMML) (1) Diffuse large B cell lymphoma (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top